Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

130945 Press Releases
DateTitleCompany
28 Jul 16 Nicox raises €18 million to finance development of its pipeline NICOX,
Published by
GlobeNewswire
28 Jul 16 ASLAN Pharmaceuticals Enters Service Agreement with Selexis SA for Development of a Proprietary Cell Line for Expression of ASLAN004 ASLAN Pharmaceuticals ,
Published by
PharmiWeb.com
28 Jul 16 Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis Almirall ,
Published by
PharmiWeb.com
28 Jul 16 DBV Technologies Reports Interim Financial Results for the First Half of 2016 Published by
GlobeNewswire
28 Jul 16 Financière de Tubize SA: 2016 half-year financial report Financière de Tubize SA,
Published by
GlobeNewswire
28 Jul 16 DBV Technologies Reports Interim Financial Results for the First Half of 2016 DBV Technologies,
Published by
GlobeNewswire
28 Jul 16 FDA approves lixisenatide as AdlyxinTM for the treatment of adults with type 2 diabetes in the U.S. Published by
GlobeNewswire
28 Jul 16 Chugai's Emicizumab Showed Continued Benefits in Patients with Hemophilia A Chugai Pharmaceutical Co., Ltd.,
Published by
Business Wire
28 Jul 16 Atropine Sulfate Industry Global Manufacturers' Analysis and 2021 Foresight RnR Market Research,
Published by
PR Newswire
28 Jul 16 Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
27 Jul 16 MacroGenics Announces Date of Second Quarter 2016 Financial Results Conference Call Published by
GlobeNewswire
27 Jul 16 Sharecare Acquires Healthways’ Population Health Business, Secures Leadership Position in Employer and Health Plan Markets Published by
GlobeNewswire
27 Jul 16 FDA Accepts BLA for BioMarin’s Cerliponase Alfa for CLN2 Disease, Form of Batten Disease Published by
GlobeNewswire
27 Jul 16 CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year Update Published by
GlobeNewswire
27 Jul 16 Vitae Pharmaceuticals Appoints Daniel M. Junius to Board of Directors Published by
GlobeNewswire
27 Jul 16 Envisia Therapeutics Announces Presentation At 2016 Ophthalmic Drug Development Summit Envisia Therapeutics,
Published by
PR Newswire
27 Jul 16 Teva to Report Second Quarter 2016 Financial Results on August 4, 2016 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Jul 16 PerkinElmer Elects Frank Witney to Board of Directors PerkinElmer, Inc.,
Published by
Business Wire
27 Jul 16 Karyopharm to Present Updated Phase 2 Clinical Data from SIGN Study at European Society of Medical Oncology 2016 Annual Meeting Published by
GlobeNewswire
27 Jul 16 Invuity Announces Proposed Public Offering of Common Stock Published by
GlobeNewswire
27 Jul 16 Fibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa Published by
GlobeNewswire
27 Jul 16 Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex™ Donepezil Transdermal System Published by
GlobeNewswire
27 Jul 16 BioMarin Provides Positive Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A in Late Breaking Oral Presentation at the World Federation of Hemophilia (WFH) 2016 World Congress Published by
GlobeNewswire
27 Jul 16 Argos Therapeutics Announces Proposed Public Offering of Common Stock and Warrants Published by
GlobeNewswire
27 Jul 16 uniQure Presents Updated Clinical Data in Patients with Severe Hemophilia B Demonstrating up to 9 Months of Sustained Levels of Factor IX Activity and Therapeutic Effect Published by
GlobeNewswire
27 Jul 16 Kite Pharma Announces Exclusive License with the National Institutes of Health for Fully Human Anti-CD19 Chimeric Antigen Receptor (CAR) Product Candidate to Treat B-Cell Malignancies Kite Pharma, Inc.,
Published by
Business Wire
27 Jul 16 RELIEF THERAPEUTICS Holding AG Announces Signing of a Term Sheet to Acquire FirstString Research, Inc. RELIEF THERAPEUTICS Holding AG,
Published by
Business Wire
27 Jul 16 Chase Pharmaceuticals Presents Phase 2 Results for CPC-201 at 2016 Alzheimer’s Association International Conference Chase Pharmaceuticals Corporation,
Published by
Business Wire
27 Jul 16 vTv Therapeutics Announces Presentation of Phase 2b Azeliragon Results at the 2016 Alzheimer’s Association International Conference (AAIC) vTv Therapeutics Inc.,
Published by
Business Wire
27 Jul 16 Vascular Solutions to Present at the Canaccord Genuity Growth Conference Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.